"/> Invitrogen™ Peptide synthétique MAP1 humain | B-LABO France

Invitrogen™ Peptide synthétique MAP1 humain

Réf. : BL-RE-175873Réf. fabricant : 15276339 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
64112
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q96BY2
Nom usuel
Human MAP1
Marque
Invitrogen

MAP1 Synthetic Peptide, PEP-0117, from Invitrogen.

Apoptosis plays a major role in normal organism development, tissue homeostasis, and removal of damaged cells. Disruption of this process has been implicated in a variety of diseases such as cancer. Members of the Bcl-2 family are known to be critical regulators of this process. These proteins are characterized by the presence of several conserved motifs termed Bcl-2 homology (BH) domains. A related protein termed MAP-1 has recently been identified. This protein contains a BH3-like domain and induces caspase-dependent apoptosis in mammalian cells when overexpressed. It forms homodimers and associates with Bcl-2 family members such as Bax, Bcl-2, and Bcl-XL in vitro and in vivo. It has been suggested that MAP-1 associates with the tumor suppressor RASSF1A following death receptor activation, allowing a conformational change in Bax that leads to cellular apoptosis.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175873
Réf. fabricant15276339
Gene ID (Entrez)64112
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ96BY2
Nom usuelHuman MAP1
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)MOAP1
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.